Photo by joshuafernandez from unsplash
Methotrexate (MTX) is the first‐line medicine to treat psoriasis. So far, there has been less research on protein biomarkers to predict its efficacy by the proteomic technique. Click to show full abstract
Methotrexate (MTX) is the first‐line medicine to treat psoriasis. So far, there has been less research on protein biomarkers to predict its efficacy by the proteomic technique.
Keywords:
itraq based;
methotrexate;
based quantitative;
quantitative proteomics;
predict efficacy;
psoriasis
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!